| Literature DB >> 28335517 |
Patricia Reboredo-Rodríguez1, María Figueiredo-González2, Carmen González-Barreiro3, Jesús Simal-Gándara4, María Desamparados Salvador5, Beatriz Cancho-Grande6, Giuseppe Fregapane7.
Abstract
Virgin olive oil, the main fat of the Mediterranean diet, is per se considered as a functional food-as stated by the European Food Safety Authority (EFSA)-due to its content in healthy compounds. The daily intake of endogenous bioactive phenolics from virgin olive oil is variable due to the influence of multiple agronomic and technological factors. Thus, a good strategy to ensure an optimal intake of polyphenols through habitual diet would be to produce enriched virgin olive oil with well-known bioactive polyphenols. Different sources of natural biological active substances can be potentially used to enrich virgin olive oil (e.g., raw materials derived from the same olive tree, mainly olive leaves and pomaces, and/or other compounds from plants and vegetables, mainly herbs and spices). The development of these functional olive oils may help in prevention of chronic diseases (such as cardiovascular diseases, immune frailty, ageing disorders and degenerative diseases) and improving the quality of life for many consumers reducing health care costs. In the present review, the most relevant scientific information related to the development of enriched virgin olive oil and their positive human health effects has been collected and discussed.Entities:
Keywords: endothelial dysfunction; enriched olive oil; functional food; health; intestinal immune function; oxidative stress; phenolic compounds
Mesh:
Substances:
Year: 2017 PMID: 28335517 PMCID: PMC5372680 DOI: 10.3390/ijms18030668
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Sources of natural bioactive ingredients and extraction conditions for the development of novel functional virgin olive oil (VOOs).
| Source/Ingredient | Extraction Method and Conditions | Observed Functional Effect in Enriched Olive Oil | Reference |
|---|---|---|---|
| SLE: directly in the oil (organic-solvent free), dynamic extraction chamber, USAE (25 °C, 20 min) | Increased oxidative stability | [ | |
| SLE and LLE with ethanol, MAE (8–10 min, 200–400 W) | Increased oxidative stability | [ | |
| SLE: ethanol/water (70:30), overnight stirring | Increased oxidative stability | [ | |
| SLE: methanol and 1,2-propanediol, hydrolyzate (HCl 2 M, 100 °C for 1 h) | Increased phenolic content in fried foodstuffs | [ | |
| LLE with ethyl acetate (for vegetative water) and SLE with ethanol/water (80:20; for solid residue) | Increased oxidative stability and antioxidant capacity | [ | |
| ASE with ethanol/water (80:20 at 80 °C) | Increased oxidative stability and antioxidant capacity | [ | |
| ASE with ethanol/water (80:20 at 80 °C), enrichment with 0.3% of emulsifier (lecithin or monoglycerides) and USAE | Lecithin is more effective increasing oxidative stability and antioxidant capacity | [ | |
| Aqueous extracts with or without the use of lecithin | Increased oxidative stability | [ | |
| Semi-preparative HPLC | Increased antioxidant capacity | [ | |
| Technological conditions during crushing (milling intensity) and malaxation (temperature and time) | Increased oxidative stability and antioxidant capacity | [ | |
| Infusion: 10%–20% up to 30 days | Reduced oxidative stability | [ | |
| SFE at 40 °C and 15–23 MPa | Reduced oxidative stability | [ | |
| Infusion: 20–40 g/L up to 7 months | Increased oxidative stability | [ | |
| Infusion: 5% for 15 days | Increased oxidative stability for rosemary > thyme and > lemon | [ | |
| Co-processing (pressing, crushing and malaxation): 3%–20% into olives | Reduced stability, expect garlic | [ | |
| Infusion: 15% with USAE (1 W/cm2) for 15 min | Not determined | [ | |
| Infusion: 20% during 2 months | Unchanged oxidative stability | [ | |
| ASE: ethanol/water (80:20) at 80 °C and up to 1500 psi | Increased antioxidant capacity | [ | |
| Addition of 0.05% of essential oil | Increased oxidative stability | [ | |
| Infusion by stirring at 1000 rpm for 3 h | Increased oxidative stability | [ | |
| Addition of 200 mg/L of essential oil | Not clear effect on oxidative stability | [ | |
| Infusion: 10 g/L during three months at room temperature | Increased oxidative stability | [ | |
| Infusion: 1%–5% at 60 °C for 40 days | Increased antioxidant capacity. Reduced oxidative stability | [ | |
| Infusion: 10%–20%, 7 days stirring at 15–18 °C vs. combined malaxation | Antioxidant activity was significantly lower in the oils obtained by infusion | [ | |
| 1.5% at room temperature, infusion for 6 h vs. USAE for 30 min | Increased oxidative stability (OSI, but not for PV or Ks) | [ | |
| Infusion (10 g/L for 15 days at room temperature) vs. co-malaxation (10 g/kg with or without 6 min USAE, before kneading) | Increased antioxidant capacity (especially with thyme) | [ | |
| 0.5%–5% by co-processing (milling and/or malaxation) | Increased antioxidant capacity | [ | |
| 0.5%–5% by co-processing (milling and/or malaxation) | Statistically significant differences in sensory testing, except in apple and rocket | [ | |
| SLE with tomato pulp and VOO at high mechanical mixing (patented) | Enhanced antioxidant status in humans | [ | |
| Co-milling of tomato seed or skin and olives | Significant enrichment in carotenoids, especially in lycopene | [ |
Oxidative stability or shelf-life, determined by peroxide value (PV), Ks or oxidative stability index (OSI/Rancimat). Antioxidant capacity, determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH), oxygen radical antioxidant capacity (ORAC) or 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assays. ASE: Accelerated extraction system; HPLC: High-performance liquid chromatography; LLE: Liquid–liquid extraction; MAE: Microwave assisted extraction; SFE: Supercritical fluid extraction; SLE: Solid–liquid extraction; USAE: Ultrasound assisted extraction.
Figure 1Cellular enzymes and mechanisms involved in protection from reactive oxygen species (ROS). SOD: Superoxide dismutase; CAT: Catalase; GPx: Glutathione peroxidase; GCL: Glutamate-cysteine ligase; GR: Glutathione reductase; GSH: Glutathione; GSSH: Oxidized glutathione; NADP+/NADPH: Nicotinamide adenine dinucleotide phosphate (oxidased/reduced).
Figure 2Postprandial time-course changes in ischemic reactive hyperemia (IRH) after ingestion of the different olive oils (OOs). CVOO: control virgin olive oil; FVOO: functional virgin olive oil enriched with its phenolic compounds (500 ppm). *, P < 0.05 versus baseline; †, P < 0.05 versus VOO at the same time-point. Figure reproduced with permission from Valls et al. [85].
Figure 3Role of low-density lipoproteins (LDLs) and early stages involved in atherosclerosis. Figure reproduced with permission from Barter [91]. LDL-C: LDL-cholesterol; MCP-1: Monocyte chemotactic protein-1.
Figure 4Effect of hydroxytyrosol (HTyr, or HT) and HT metabolites on E-selectin, P-selectin, VCAM-1, ICAM-1, and MCP-1 protein secretion in human aortic endothelial cells (HAEC) stimulated by TNF-α after 24 h. Human aortic endothelial cells were co-incubated with HT or HT metabolites at 1, 2, 5, and 10 μM and TNF-α (10 ng/mL) for 24 h. (A) Effect of HT or HT metabolites on E-selectin protein secretion. (B) Effect of HT or HT metabolites on P-selectin protein secretion. (C) Effect of HT or HT metabolites on VCAM-1 protein secretion. (D) Effect of HT or HT metabolites on ICAM-1 protein secretion. (E) Effect of HT or HT metabolites on MCP-1 protein secretion. Results are expressed as the percentage of soluble cellular adhesion molecules or chemokine protein secretion adjusted by total cellular protein and standard error of the mean (SEM; error bars). *, P < 0.05 versus TNF-α alone. †, P < 0.05 compared between HT and HT metabolites at the same concentration. Figure reproduced with permission from Catalán et al. [13]. TCP: Tissue culture plate; TNF-α: Tumour necrosis factor-alpha; VCAM-1: Vascular cell adhesion molecule-1; ICAM-1: Intercellular adhesion molecule-1; MCP-1: Monocyte chemotactic protein-1.
Figure 5Changes in atherogenic lipoprotein particle atherogenic ratios and lipoprotein insulin resistance index (LP-IR) after consumption of functional olive oils versus natural virgin olive oil (VOO). FVOO: Functional virgin olive oil enriched with its phenolic compounds (500 ppm); FVOOT: Functional olive enriched with its phenolic compounds (250 ppm) and those from thyme (250 ppm). *, P < 0.001 versus VOO. Differences between functional olive oils are indicated by square brackets with the corresponding significance. Figure reproduced with permission from Fernández-Castillejo et al. [34]. HDL: high-density lipoprotein; HDL-C: HDL-cholesterol; LDL-P: low density lipoprotein-particles; HDL-P: HDL-particles; s-HDL: small HDL; l-HDL: large HDL.
Figure 6Stages involved in the reverse cholesterol transport (RCT), which favours the cholesterol transport to the liver for its excretion. Figure reproduced with permission from Oliveira and De Faria, 2011 [99]. LDLr: LDL receptors; LRP: LDL receptor-related proteins; CE: Cholesteryl ester; SR-BI: Scavenger receptor class B type I; VLDL: Very low-density lipoprotein; LH: Hepatic lipase; IDL: Intermediate-density lipoproteins; TG: Triglycerides; CETP: Cholesterylester transfer protein; LCAT: lecithin cholesterol acyl transferase; ABCA1/G1: ATP binding cassette transporter A1 or G1; Apo AI: Apolipoprotein AI.
Figure 7Venn diagram showing intersections of proteins differentially expressed after VOO, FVOO, and FVOOT interventions. Proteins are presented with their gene encode symbol. Red proteins: Up-regulated; Green proteins: Down-regulated. Figure reproduced with permission from Pedret et al. [100]. VOO: Virgin olive oil; FVOO: Functional virgin olive oil enriched with its own phenolic compounds; FVOOT: Functional virgin olive oil enriched with its own phenolic compounds plus complementary phenols from thyme.